Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Live Webinar: Poker face revealed: Using facial analysis to reveal deeper emotional insights

    February 4, 2019 | Facial analysis, Pharma, digital health, healthcare, webinar 

    Thursday 28th February 2019, 10:00 EST / 15:00 GMT / 16:00 CET

    Thursday 28th February 2019
    10:00 EST / 15:00 GMT / 16:00 CET
    Register now to secure your place » 

    Does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions. Brief, involuntary flashes of emotion or ‘micro-expressions’ can reveal a lot about a person’s true feelings. As market researchers interested in the emotional responses driving people’s attitudes and behaviours, this information is invaluable but can often be difficult to obtain. One of the latest innovations in market research is facial analysis, which uses recognition software to detect a range of emotions in faces.

    Register now to secure your place » 

    Join us for this complimentary webinar event hosted in partnership with emotion measurement company, Affectiva, which has analysed over 5,000,000 faces and 24,000 adverts to understand how people respond to digital stimulus such as advertisements, websites and smartphone apps. We will demonstrate how, over the past several years, we’ve been using facial analysis in both qualitative and quantitative settings to delve further into respondents’ reactions to healthcare communications.

    What are the key takeaways?

    The theory
    Learn more about the science and technology underpinning facial and emotional analysis.

    Applications in healthcare MRX
    Discover how we used facial analysis to deliver additional insights in a pharmaceutical setting.

    Key considerations
    Find out about the logistical challenges of using this methodology and how to overcome them.

    Looking forwards
    Explore future applications of facial analysis including integration with other technologies.

    Gain answers to your key questions
    At the end of the webinar there will be a live Q&A session. Start the conversation by submitting your questions in advance when you register.

    Thursday 28th February 2019
    10:00 EST / 15:00 GMT / 16:00 CET
    Register now to secure your place »

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    RP Investigates – Q&A session: Living with Lupus

    In this 45-minute session, Head of Living With, Mariel Metcalfe spoke to Brenda, who was diagnosed with Lupus 12 years ago.

    Webcast: Demand Assessment

    Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

    White paper: Are we prepared for the influx of CAR-Ts?

    Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

    New syndicated patient report – Living with Lupus US

    Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

    Video: Emotion AI

    Artificial intelligence is revolutionising the way we conduct healthcare market research.

    Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

    Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

    Webcast: Virtual Q&A session – The future of digital health

    In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

    Research Partnership is on the rise

    Research Partnership ranks 12th in fastest growing UK market research agency league  tables

    What does the future hold for Light-chain Amyloidosis?

    Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

    Webcast: Securing a future for telehealth with immersive market research insights

    Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.